SynthesisScientific reports2023

Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive-compulsive disorder: a systematic review and meta-analysis of randomized clinical trials.

Negin Eissazade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.